Media Summary: Cardiovascular Adverse Events in Oncology Trials: Understanding and Appreciating the Differences Between Clinical Trial Data ... In the effort to better promote public health and protect patient safety, there is growing interest in developing a systematic ... Adriana Kiędzierska-Mencfeld, PhD, CEO of Rezon

Asa Biop Webinar Innovative Study - Detailed Analysis & Overview

Cardiovascular Adverse Events in Oncology Trials: Understanding and Appreciating the Differences Between Clinical Trial Data ... In the effort to better promote public health and protect patient safety, there is growing interest in developing a systematic ... Adriana Kiędzierska-Mencfeld, PhD, CEO of Rezon Our speaker is Daniel Sabanés Bové who is Senior Principal Data Scientist at F. Hoffmann-La Roche Ltd, where he leads a team ... Join us for a panel discussion on commercializing biomedical We are pleased to announce an exciting seminar on clinical trial

Photo Gallery

ASA BIOP Webinar: Innovative Study Design: Clinical Need and Reasoning drive Statistical Decisions
ASA BIOP Webinar: Cardiovascular Adverse Events in Oncology Trials
ASA Safety Working Group Quarterly Scientific Webinar  2025 Q4
ASA Fellowship webinar
ASA Safety Working Group Quarterly Scientific Webinar   2025 Q3
Beyond the Bite: Webinar 2 - Biologicals
Enabling Affordable Biologics Through Advanced Process Optimization: A Manufacturing Case Study
Webinar: The Scale-Up Journey of Biobased Processes: Real-World Challenges, Surprises and Success
ASA for Prevention of Vascular Events
January 2023 ASA Biopharmaceutical Section (BIOP) Software Engineering Working Group (SWE WG)
From lab to launch: Navigating the path from academia to commercialization
Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development
View Detailed Profile
ASA BIOP Webinar: Innovative Study Design: Clinical Need and Reasoning drive Statistical Decisions

ASA BIOP Webinar: Innovative Study Design: Clinical Need and Reasoning drive Statistical Decisions

Innovative Study

ASA BIOP Webinar: Cardiovascular Adverse Events in Oncology Trials

ASA BIOP Webinar: Cardiovascular Adverse Events in Oncology Trials

Cardiovascular Adverse Events in Oncology Trials: Understanding and Appreciating the Differences Between Clinical Trial Data ...

ASA Safety Working Group Quarterly Scientific Webinar  2025 Q4

ASA Safety Working Group Quarterly Scientific Webinar 2025 Q4

In the effort to better promote public health and protect patient safety, there is growing interest in developing a systematic ...

ASA Fellowship webinar

ASA Fellowship webinar

The

ASA Safety Working Group Quarterly Scientific Webinar   2025 Q3

ASA Safety Working Group Quarterly Scientific Webinar 2025 Q3

In the effort to better promote public health and protect patient safety, there is growing interest in developing a systematic ...

Beyond the Bite: Webinar 2 - Biologicals

Beyond the Bite: Webinar 2 - Biologicals

Second

Enabling Affordable Biologics Through Advanced Process Optimization: A Manufacturing Case Study

Enabling Affordable Biologics Through Advanced Process Optimization: A Manufacturing Case Study

Adriana Kiędzierska-Mencfeld, PhD, CEO of Rezon

Webinar: The Scale-Up Journey of Biobased Processes: Real-World Challenges, Surprises and Success

Webinar: The Scale-Up Journey of Biobased Processes: Real-World Challenges, Surprises and Success

WEBINAR

ASA for Prevention of Vascular Events

ASA for Prevention of Vascular Events

To join the newsletters for the

January 2023 ASA Biopharmaceutical Section (BIOP) Software Engineering Working Group (SWE WG)

January 2023 ASA Biopharmaceutical Section (BIOP) Software Engineering Working Group (SWE WG)

Our speaker is Daniel Sabanés Bové who is Senior Principal Data Scientist at F. Hoffmann-La Roche Ltd, where he leads a team ...

From lab to launch: Navigating the path from academia to commercialization

From lab to launch: Navigating the path from academia to commercialization

Join us for a panel discussion on commercializing biomedical

Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development

Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development

We are pleased to announce an exciting seminar on clinical trial

Inhibitory Learning Model Webinar

Inhibitory Learning Model Webinar

In this